Overview: In this program Dr. Barkley provides detailed information on the specific nature of ADHD symptoms as revealed by clinical research so as to better inform the current diagnostic criteria for ADHD. He then reviews the various modifications necessary for updating the DSM criteria and making them more useful with special populations (girls, adults, etc.).
He also addresses the changes that are still needed to improve these diagnostic criteria based on findings in the research literature. Dr. Barkley then addresses the issue of subtyping of ADHD along with the emerging conclusion that one form of the inattentive type may constitute a new disorder known in research as sluggish cognitive tempo or sometimes called ADD by clinicians.
Why should you Attend: Attendance will familiarize you with the latest criteria for diagnosing ADHD in children and adults including not just the DSM-5 criteria, but also the modifications that are essential for applying those diagnostic criteria to special populations (girls, adults, etc.). These modifications were well documented in research over the past decade yet went ignored in the final version of DSM-5. You will find that clinicians can not afford to ignore such evidenced-based adjustments that permit a more rigorous approach to the diagnosis of ADHD than that permitted in the DSM-5 criteria.
These criteria will also be further informed by the latest clinical research perspective on the nature of ADHD as a disorder of executive functioning and self-regulation. The clinical implications of this perspective are far more useful for understanding the management of ADHD than is the attention deficit perspective.
Furthermore, those attending will learn about the new disorder of attention known as sluggish cognitive tempo that has come to replace the earlier Inattentive Type of ADHD, a subtype no longer recognized in DSM-5 as it has been demoted to a presentation. You won’t want to miss out on these cutting edge discoveries and their clinical implications as presented by an international authority on ADHD who tracks the published research findings weekly and brings those findings into his presentations.
Areas Covered in the Session:
The current research clinical view of ADHD
The nature of the attention and inhibition problems evident in ADHD
Understanding ADHD as a disorder of executive functioning
The DSM-5 criteria
The problems with DSM-5 criteria and how to fix them
The problems with earlier DSM subtyping of ADHD and a more recent alternative approach
The nature of sluggish cognitive tempo – a distinct disorder of attention from ADHD that can be comorbid with it
Price - $139
Netzealous LLC - MentorHealth
Phone No: 1-800-385-1607
Webinar Sponsorship: https://www.mentorhealth.com/control/webinar-sponsorship/